Pacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
PACBPacific Biosciences of California(PACB) Zacks Investment Research·2024-05-10 07:31

For the quarter ended March 2024, Pacific Biosciences of California (PACB) reported revenue of 38.81million,down0.238.81 million, down 0.2% over the same period last year. EPS came in at -0.26, compared to -0.31intheyear−agoquarter.Thereportedrevenuerepresentsasurpriseof+0.080.31 in the year-ago quarter. The reported revenue represents a surprise of +0.08% over the Zacks Consensus Estimate of 38.78 million. With the consensus EPS estimate being -$0.26, the company has not delivered EPS surprise. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings ...